As of Monday noon (23 Nov), the Ministry of Health (MOH) has confirmed five new cases of COVID-19 infection.

This brings the total number of infection cases to 58,165.

There are no new cases of locally transmitted COVID-19 infection.

All of the five new cases are imported cases, who had already been placed on Stay-Home Notice or isolated upon arrival in Singapore.

All new cases today are asymptomatic and were detected from screening and surveillance.

Amongst the 5 imported cases, 1 (Case 58369) is a Singaporean who returned from India. Another 3 (Cases 58370, 58371 and 58372) are Work Permit holders currently employed in Singapore who arrived from Indonesia.

The remaining case (Case 58368), a Short-Term Visit Pass holder who arrived from France, is an engineer on a work project in Singapore.

There are no new cases linked to existing or new clusters today.

Update on condition of confirmed cases

4 more cases of COVID-19 infection have been discharged from hospitals or community isolation facilities. In all, 58,071 have fully recovered from the infection and have been discharged from hospitals or community care facilities.

There are currently 36 confirmed cases who are still in the hospital. Of these, most are stable or improving, and 1 is in critical condition in the intensive care unit. 30 are isolated and cared for at community facilities. These are those who have mild symptoms or are clinically well but still test positive for COVID-19.

28 have passed away from complications due to COVID-19 infection.

Subscribe
Notify of
2 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

UNODC Philippines raises concerns on mental well-being of prisoners and prison workers during COVID-19 pandemic

The Philippines — The high concentration of prisons in the Philippines implicates…

Singapore’s Health Sciences Authority approves Pfizer’s PCV20 vaccine for adults over 18

Pfizer’s 20-valent pneumococcal conjugate vaccine, APEXXNAR, has been approved by the Singapore Health Sciences Authority for adults aged 18 and above, becoming the first 20-valent pneumococcal conjugate vaccine to be approved in Southeast Asia. The vaccine offers protection against invasive pneumococcal disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.

Two cruise ships to be assessed for use as temporary accommodation for foreign workers

Earlier today (17 April), Singapore Tourism Board released a press statement announcing…

COVID jab maker BioNTech to build SE Asia manufacturing site

COVID jab maker BioNTech said Monday it would build a southeast Asia…